S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 40 of 49

Issue Date	Title / Author(s) / Citation	File
2005-08	The signaling network of transforming growth factor β1, protein kinase C delta, and integrin underlies the spreading and invasiveness of gastric carcinoma cells Lee, Mi-Sook; Kim, Tae Young; Kim, Yong-Bae; Lee, Sung-Yul; Ko, Seong-Gyu; Jong, Hyun-Soon; Kim, Tae-You; Bang, Yung-Jue; Lee, Jung Weon Molecular and Cellular Biology, Vol.25 No.16, pp.6921-6936	view file DOI
2009-08	Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinoma Sim, Sung Hoon; Han, Sae-Won; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Chung, Doo Hyun; Kim, Tae-You; Lee, Jong Seok; Kim, Young Whan; Heo, Dae Seog; Bang, Yung-Jue Lung Cancer, Vol.65 No.2, pp.204-207	DOI
2011-06	Bidirectional pharmacodynamic interaction between pegylated liposomal CKD-602 (S-CKD602) and monocytes in patients with refractory solid tumors Zamboni, William C.; Maruca, Lauren J.; Strychor, Sandra; Zamboni, Beth A.; Ramalingam, Suresh; Edwards, Robert P.; Kim, J. K.; Bang, Y. J.; Lee, H. Y.; Friedland, David M.; Stoller, Ronald G.; Belani, Chandra P.; Ramanathan, Ramesh K. Journal of Liposome Research, Vol.21 No.2, pp.158-165	DOI
2012-01	Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial Gianni, Luca; Pienkowski, Tadeusz; Im, Young-Hyuck; Roman, Laslo; Tseng, Ling-Ming; Liu, Mei-Ching; Lluch, Ana; Staroslawska, Elzbieta; de la Haba-Rodriguez, Juan; Im, Seock-Ah; Pedrini, Jose Luiz; Poirier, Brigitte; Morandi, Paolo; Semiglazov, Vladimir; Srimuninnimit, Vichien; Bianchi, Giulia; Szado, Tania; Ratnayake, Jayantha; Ross, Graham; Valagussa, Pinuccia The Lancet Oncology, Vol.13 No.1, pp.25-32	DOI
2012-01	Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer Baselga, Jose; Cortes, Javier; Kim, Sung-Bae; Im, Seock-Ah; Hegg, Roberto; Im, Young-Hyuck; Roman, Laslo; Pedrini, Jose Luiz; Pienkowski, Tadeusz; Knott, Adam; Clark, Emma; Benyunes, Mark C.; Ross, Graham; Swain, Sandra M. New England Journal of Medicine, Vol.366 No.2, pp.109-119	DOI
2012-05	Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial van der Graaf, Winette T. A.; Blay, Jean-Yves; Chawla, Sant P.; Kim, Dong-Wan; Binh Bui-Nguyen; Casali, Paolo G.; Schoffski, Patrick; Aglietta, Massimo; Staddon, Arthur P.; Beppu, Yasuo; Le Cesne, Axel; Gelderblom, Hans; Judson, Ian R.; Araki, Nobuhito; Ouali, Monia; Marreaud, Sandrine; Hodge, Rachel; Dewji, Mohammed R.; Coens, Corneel; Demetri, George D.; Fletcher, Christopher D.; Tos, Angelo Paolo Dei; Hohenberger, Peter The Lancet, Vol.379 No.9829, pp.1879-1886	DOI
2012-06	Remarkable Tumor Response to Crizotinib in a 14-Year-Old Girl With ALK-Positive Non-Small-Cell Lung Cancer Kim, Su-Jung; Kim, Dong-Wan; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog; Bang, Yung-Jue Journal of Clinical Oncology, Vol.30 No.16, pp.E147-E150	DOI
2012-12	Phase 2 Study of Everolimus Monotherapy in Patients With Nonfunctioning Neuroendocrine Tumors or Pheochromocytomas/Paragangliomas Oh, Do-Youn; Kim, Tae-Won; Park, Young Suk; Shin, Sang Joon; Shin, Seong Hoon; Song, Eun-Kee; Lee, Hyo Jin; Lee, Kewn-Wook; Bang, Yung-Jue Cancer, Vol.118 No.24, pp.6162-6170	DOI
2013-01	Multiplexed Gene Expression and Fusion Transcript Analysis to Detect ALK Fusions in Lung Cancer Lira, Maruja E.; Kim, Tae Min; Huang, Donghui; Deng, Shibing; Koh, Youngil; Jang, Bogun; Go, Heounjeong; Lee, Se-Hoon; Chung, Doo Hyun; Kim, Woo Ho; Schoenmakers, Eric F. P. M.; Choi, Yoon-La; Park, Keunchil; Ahn, Jin Seok; Sun, Jong-Mu; Ahn, Myung-Ju; Kim, Dong-Wan; Mao, Mao Journal of Molecular Diagnostics, Vol.15 No.1, pp.51-61	DOI
2013-01	Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation Kang, Yoon-Koo; Kang, Byung Woog; Im, Seock-Ah; Lee, Jae-Lyun; Park, Sook Ryun; Kang, Won Ki; Chang, Heung Moon; Kim, Tae Won; Oh, Do-Youn; Jung, Kyung Hae; Ryu, Min-Hee Cancer Chemotherapy and Pharmacology, Vol.71 No.1, pp.43-51	DOI
2013-09	How Molecular Understanding Affects to Prescribing Patterns and Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer? 10 Year Experience of Single Institution Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog Cancer Research and Treatment, Vol.45 No.3, pp.178-185	view file DOI
2014-10	Safety and Efficacy of Dacomitinib in Korean Patients with KRAS Wild-Type Advanced Non-Small-Cell Lung Cancer Refractory to Chemotherapy and Erlotinib or Gefitinib A Phase I/II Trial Park, Keunchil; Cho, Byoung C.; Kim, Dong-Wan; Ahn, Myung-Ju; Lee, Sang-Yoon; Gernhardt, Diana; Taylor, Ian; Campbell, Alicyn K.; Zhang, Hui; Giri, Nagdeep; Letrent, Stephen P.; O'Connell, Joseph; Heo, Dae S. Journal of Thoracic Oncology, Vol.9 No.10, pp.1523-1531	DOI
2014-12	Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial Jaenne, Pasi A.; Ou, Sai-Hong I.; Kim, Dong-Wan; Oxnard, Geoffrey R.; Martins, Renato; Kris, Mark G.; Dunphy, Frank; Nishio, Makoto; O'Connell, Joseph; Paweletz, Cloud; Taylor, Ian; Zhang, Hui; Goldberg, Zelanna; Mok, Tony The Lancet Oncology, Vol.15 No.13, pp.1433-1441	DOI
2016-01	Gefitinib-induced interstitial lung disease in korean lung cancer patients Beom, Seung-Hoon; Kim, Dong-Wan; Sim, Sung Hoon; Keam, Bhumsuk; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Heo, Dae Seog Cancer Research and Treatment, Vol.48 No.1, pp.88-97	view file DOI
2016-03	A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806) Lim, Sun Min; Cho, Byoung Chul; Kim, Sang-We; Kang, Seok Yun; Heo, Dae Seog; Kim, Heung Tae; Lee, Dae Ho; Kim, Dong-Wan; Jung, Minkyu; Choi, Jin-Hyuk; Shim, Hyo Sup; Choi, Jong Rak; Kim, Joo-Hang Lung Cancer, Vol.93, pp.1-8	DOI
2016-05	The prognostic impacts of postoperative radiotherapy in the patients with resected anaplastic thyroid carcinoma: A systematic review and meta-analysis Kwon, Jeanny; Kim, Byoung Hyuck; Jung, Hee-Won; Besic, Nikola; Sugitani, Iwao; Wu, Hong-Gyun European Journal of Cancer, Vol.59, pp.34-45	DOI
2016-07	Src as a Therapeutic Target in Biliary Tract Cancer Nam, Ah-Rong; Kim, Ji-Won; Park, Ji Eun; Bang, Ju-Hee; Jin, Mei Hua; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue Molecular Cancer Therapeutics, Vol.15 No.7, pp.1515-1524	DOI
2016-11	Palbociclib and Letrozole in Advanced Breast Cancer Finn, Richard S.; Martin, Miguel; Rugo, Hope S.; Jones, Stephen; Im, Seock-Ah; Gelmon, Karen; Harbeck, Nadia; Lipatov, Oleg N.; Walshe, Janice M.; Moulder, Stacy; Gauthier, Eric; Lu, Dongrui R.; Randolph, Sophia; Dieras, Veronique; Slamon, Dennis J. New England Journal of Medicine, Vol.375 No.20, pp.1925-1936	DOI
2017-02	Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial Lee, Se-Hoon; Lee, J. -K.; Ahn, M. -J.; Kim, D. -W.; Sun, J. -M.; Keam, B.; Kim, T. M.; Heo, D. S.; Ahn, J. S.; Choi, Y. -L.; Min, H. -S.; Jeon, Y. K.; Park, K. Annals of Oncology, Vol.28 No.2, pp.292-297	DOI
2017-09	Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial Cortes, Javier; Rugo, Hope S.; Awada, Ahmad; Twelves, Chris; Perez, Edith A.; Im, Seock-Ah; Gomez-Pardo, Patricia; Schwartzberg, Lee S.; Dieras, Veronique; Yardley, Denise A.; Potter, David A.; Mailliez, Audrey; Moreno-Aspitia, Alvaro; Ahn, Jin-Seok; Zhao, Carol; Hoch, Ute; Tagliaferri, Mary; Hannah, Alison L.; O'Shaughnessy, Joyce Breast Cancer Research and Treatment, Vol.165 No.2, pp.329-341	DOI
2017-12	Active maintenance of endothelial cells prevents kidney fibrosis Yang, Seung Hee; Kim, Yong Chul; An, Jung Nam; Kim, Jin Hyuk; Lee, Juhoh; Lee, Hee-Yoon; Cho, Joo-Youn; Paik, Jin Ho; Oh, Yun Kyu; Lim, Chun Soo; Kim, Yon Su; Lee, Jung Pyo Kidney Research and Clinical Practice, Vol.36 No.4, pp.329-341	DOI
2018-05	Phase II study of crizotinib in east asian patients with ROS1-positive advanced non–small-cell lung cancer Wu, Yi-Long; Yang, James Chih-Hsin; Kim, Dong-Wan; Lu, Shun; Zhou, Jianying; Seto, Takashi; Yang, Jin-Ji; Yamamoto, Noboru; Ahn, Myung-Ju; Takahashi, Toshiaki; Yamanaka, Takeharu; Kemner, Allison; Roychowdhury, Debasish; Paolini, Jolanda; Usari, Tiziana; Wilner, Keith D.; Goto, Koichi Journal of Clinical Oncology, Vol.36 No.14, pp.1405-1411	DOI
2018-08	A first-in-human study of the new oral selective estrogen receptor degrader AZD9496 for ER+/HER2- advanced breast cancer Hamilton, Erika P.; Patel, Manish R.; Armstrong, Anne C.; Baird, Richard D.; Jhaveri, Komal; Hoch, Matthias; Klinowska, Teresa; Lindemann, Justin P. O.; Morgan, Shethah R.; Schiavon, Gaia; Weir, Hazel M.; Im, Seock-Ah Clinical Cancer Research, Vol.24 No.15, pp.3510-3518	DOI
2018-09	Palbociclib plus endocrine therapy in older women with HR+/HER2- advanced breast cancer: A pooled analysis of randomised PALOMA clinical studies Rugo, Hope S.; Turner, Nicholas C.; Finn, Richard S.; Joy, Anil A.; Verma, Sunil; Harbeck, Nadia; Masuda, Norikazu; Im, Seock-Ah; Huang, Xin; Kim, Sindy; Sun, Wan; Iyer, Shrividya; Schnell, Patrick; Bartlett, Cynthia Huang; Johnston, Stephen European Journal of Cancer, Vol.101, pp.123-133	DOI
2018-11	Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2 Campone, Mario; Im, Seock-Ah; Iwata, Hiroji; Clemons, Mark; Ito, Yoshinori; Awada, Ahmad; Chia, Stephen; Jagiello-Gruszfeld, Agnieszka; Pistilli, Barbara; Tseng, Ling-Ming; Hurvitz, Sara; Masuda, Norikazu; Cortes, Javier; De Laurentiis, Michele; Arteaga, Carlos L.; Jiang, Zefei; Jonat, Walter; Le Mouhaer, Sylvie; Sankaran, Banu; Bourdeau, Laurence; El-Hashimy, Mona; Sellami, Dalila; Baselga, Jose European Journal of Cancer, Vol.103, pp.147-154	DOI
2018-11	Brigatinib versus crizotinib in ALK-positive non-small-cell lung cancer Camidge, D. Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James Chih-Hsin -H.; Han, Ji-Youn; Lee, Jong-Seok; Hochmair, Maximilian J.; Li, Jacky Yu-Chung; Chang, Gee-Chen; Lee, Ki Hyeong; Gridelli, Cesare; Delmonte, Angelo; Garcia Campelo, Rosario; Kim, Dong-Wan; Bearz, Alessandra; Griesinger, Ffrank; Morabito, Alessandro; Felip, Enriqueta; Califano, Raffaele; Ghosh, Sharmistha; Spira, Alexander; Gettinger, Scott N.; Tiseo, Marcello; Gupta, Neeraj; Haney, Jeff; Kerstein, David; Popat, Sanjay New England Journal of Medicine, Vol.379 No.21, pp.2027-2039	DOI
2019-01	MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer Johnston, Stephen; Martin, Miguel; Di Leo, Angelo; Im, Seock-Ah; Awada, Ahmad; Forrester, Tammy; Frenzel, Martin; Hardebeck, Molly C.; Cox, Joanne; Barriga, Susana; Toi, Masakazu; Iwata, Hiroji; Goetz, Matthew P. npj Breast Cancer, Vol.5 No.1, p. 5	DOI
2019-04	Development of a patient-derived xenograft model of glioblastoma via intravitreal injection in mice Lee, Jooyoung; Jo, Dong Hyun; Kim, Jin Hyoung; Cho, Chang Sik; Han, Jiwon Esther; Kim, Yona; Park, Hyoungwoo; Yoo, Seung Ho; Yu, Young Suk; Moon, Hyo Eun; Park, Hye Ran; Kim, Dong Gyu; Kim, Jeong Hun; Paek, Sun Ha Experimental and Molecular Medicine, Vol.51 No.4, pp.1-9	DOI
2019-06	Challenges and insights of early oncology drug development in the Asia-Pacific region: introduction of phase I oncology clinical trial center and experience sharing for early clinical trials in Seoul National University Hospital, Korea Im, Seock-Ah; Lee, Dae-Won; Kang, Ryungwoo; Kim, Jee Hyun; Kim, Dong-Wan; Jang, In-Jin; Lee, Jong-Seok; Bang, Yung-Jue Chinese Clinical Oncology, Vol.8 No.3, p. 27	view file DOI
2019-07	Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001 Shaw, Alice Tsang; Riely, Gregory J.; Bang, Yung-Jue; Kim, Dong-Wan; Camidge, David Ross; Solomon, Benjamin J.; Varella-Garcia, Marileila; Iafrate, Anthony John; Shapiro, Geoffrey I.; Usari, Tiziana; Wang, S. C.; Wilner, Keith. D.; Clark, Jeffrey W.; Ou, Sai Hong Ignatius Annals of Oncology, Vol.30 No.7, pp.1121-1126	DOI
2019-08	Clinicopathological and Preclinical Findings of NUT Carcinoma: A Multicenter Study Jung, Minsun; Kim, Soyeon; Lee, June-Koo; Yoon, Sun Och; Park, Heae Surng; Hong, Soon Won; Park, Weon-Seo; Kim, Ji Eun; Kim, Joon; Keam, Bhumsuk; Kim, Hyun Jik; Kang, Hyoung Jin; Kim, Dong-Wan; Jung, Kyeong Cheon; Kim, Young Tae; Heo, Dae Seog; Kim, Tae Min; Jeon, Yoon Kyung Oncologist, Vol.24 No.8, pp.E740-E748	DOI
2019-08	Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: Phase Ib study Kim, Jin Won; Lee, Kyung-Hun; Kim, Ji-Won; Suh, Koung Jin; Nam, Ah-Rong; Bang, Ju-Hee; Bang, Yung-Jue; Oh, Do-Youn British Journal of Cancer, Vol.121 No.4, pp.332-339	DOI
2020-02	TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy Kim, Jin Won; Min, Ahrum; Im, Seock-Ah; Jang, Hyemin; Kim, Yu Jin; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Lee, Keun Wook; Oh, Do-Youn; Kim, Jee-Hyun; Bang, Yung-Jue Cancers, Vol.12 No.2, p. 334	view file DOI
2020-06	Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): A randomised, open-label, phase 2 trial Tolaney, Sara M.; Wardley, Andrew M.; Zambelli, Stefania; Hilton, John F.; Troso-Sandoval, Tiffany A.; Ricci, Francesco; Im, Seock-Ah; Kim, Sung-Bae; Johnston, Stephen R. D.; Chan, Arlene; Goel, Shom; Catron, Kristen; Chapman, Sonya C.; Price, Gregory L.; Yang, Zhengyu; Gainford, M. Corona; Andre, Fabrice The Lancet Oncology, Vol.21 No.6, pp.763-775	DOI
2020-11	First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer Shaw, Alice T.; Bauer, Todd M.; de Marinis, Filippo; Felip, Enriqueta; Goto, Yasushi; Liu, Geoffrey; Mazieres, Julien; Kim, Dong-Wan; Mok, Tony; Polli, Anna; Thurm, Holger; Calella, Anna M.; Peltz, Gerson; Solomon, Benjamin J. New England Journal of Medicine, Vol.383 No.21, pp.2018-2029	DOI
2021-01	Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy Kim, Seongyeong; Shin, Dongjin; Min, Ahrum; Kim, Minjung; Na, Deukchae; Lee, Han-Byeol; Ryu, Han Suk; Yang, Yaewon; Woo, Go-Un; Lee, Kyung-Hun; Lee, Dae-Won; Kim, Tae-Yong; Lee, Charles; Im, Seock-Ah; Kim, Jong-Il Journal of Translational Medicine, Vol.19 No.1, p. 7	DOI
2021-03	Modulation of Nogo receptor 1 expression orchestrates myelin-associated infiltration of glioblastoma Hong, Jun-Hee; Kang, Sangjo; Sa, Jason K.; Park, Gunwoo; Oh, Young Taek; Kim, Tae Hoon; Yin, Jinlong; Kim, Sung Soo; D'Angelo, Fulvio; Koo, Harim; You, Yeonhee; Park, Saewhan; Kwon, Hyung Joon; Kim, Chan Il; Ryu, Haseo; Lin, Weiwei; Park, Eun Jung; Kim, Youn-Jae; Park, Myung-Jin; Kim, Hyunggee; Kim, Mi-Suk; Chung, Seok; Park, Chul-Kee; Park, Sung-Hye; Kang, Yun Hee; Kim, Jong Heon; Saya, Hideyuki; Nakano, Ichiro; Gwak, Ho-Shin; Yoo, Heon; Lee, Jeongwu; Hur, Eun-Mi; Shi, Bingyang; Nam, Do-Hyun; Iavarone, Antonio; Lee, Seung-Hoon; Park, Jong Bae Brain, Vol.144 No.2, pp.636-654	DOI
2021-03	Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial Patnaik, Amita; Yap, Timothy A.; Chung, Hyun Cheol; de Miguel, Maria J.; Bang, Yung-Jue; Lin, Chia-Chi; Su, Wu-Chou; Italiano, Antoine; Chow, Kay Hoong; Szpurka, Anna M.; Yu, Danni; Zhao, Yumin; Carlsen, Michelle; Schmidt, Shelly; Vangerow, Burkhard; Gandhi, Leena; Xu, Xiaojian; Bendell, Johanna Clinical Cancer Research, Vol.27 No.5, pp.1267-1277	DOI
2021-03	Interaction of Nrf2 with dimeric STAT3 induces IL-23 expression: Implications for breast cancer progression Kim, Su-Jung; Saeidi, Soma; Cho, Nam-Chul; Kim, Seung Hyeon; Lee, Han-Byoel; Han, Wonshik; Noh, Dong-Young; Surh, Young-Joon Cancer Letters, Vol.500, pp.147-160	DOI
2021-06	Compact Fat Grafting: A Novel Method to Improve Graft Retention Through Modulation of Adipocyte Size Kim, Il-Kug; Hong, Ki Yong; Ju, Uk-Il; Choi, Bong Gyu; Jin, Ung Sik; Chun, Yang-Sook; Chang, Hak Aesthetic Surgery Journal, Vol.41 No.6, pp.NP653-NP661	DOI

1 2